hemophilia

Pharmalot Ed Silverman

Drug makers used camps, comics, and scholarships to woo kids with hemophilia

Pharmalot Ed Silverman

Biogen puzzles Wall Street with plans to spin off its hemophilia business

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: J&J ordered to pay $55m in talcum powder trial

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Biogen looks to sell off hemophilia drugs

Health Leah Samuel

Global push gives hemophilia patients in developing world access to vital drug